Abnormal Checkup Results in China: What Happens Next
Follow-up is not included in any checkup package, at any price tier, anywhere in China. If a finding is flagged, expect to pay separately — roughly ¥120–300 for a repeat targeted ultrasound, ¥50–600 for a specialist consultation, ¥900–2,000 for contrast-enhanced CT or MRI, and ¥800–2,500 for a thyroid fine-needle aspiration — and to budget two to four extra days if you resolve it in country. Most screening reports come back with something flagged; the useful skill is reading what the report is actually asking you to do.
Find the closing recommendation line and the interval attached to it. 建议复查 with "3–12 months" beside it is a routine watch instruction, not an alarm; 建议进一步检查 or 建议专科就诊 with no interval means the reporting physician wants a more specific test now. Then decide by type of next step: tests are cheap and fast in China and worth staying for; treatment is usually better started at home, where your physician and your insurer are.
How a Chinese report marks something abnormal
Chinese checkup reports are dense, highly standardised, and mostly numeric — which is good news, because the structure is learnable even if the prose is not. Laboratory results are printed with an arrow or letter against any value outside the reference range: ↑ or H for high, ↓ or L for low. Qualitative tests read 阳性 (positive) or 阴性 (negative). Imaging and ultrasound sections carry a narrative description followed by an impression, and the whole report closes with a summary page — usually titled 体检结论 or 总检意见 — that lists every abnormal finding with a recommendation beside it.
That final summary page is the one that matters, and it is the one people photograph and panic over. Here are the phrases you will meet on it.
| Chinese | Pinyin | What it is telling you |
|---|---|---|
| 未见明显异常 | wèi jiàn míngxiấn yìcháng | No obvious abnormality seen — the all-clear line for that item |
| 建议复查 | jiànyì fùchá | Repeat this test. Look for the interval: 3个月复查 = recheck in 3 months |
| 定期随访 | dìngqī suífǎng | Routine periodic follow-up — the mildest instruction on the list |
| 建议进一步检查 | jiànyì jìn yí bù jiǎnchá | Further examination recommended — the screening test can't resolve it |
| 建议专科就诊 | jiànyì zhuānkē jiùzhěn | See the relevant specialist department |
| 结节 / 囊肿 / 息肉 | jiéjié / nángzhịng / xíròu | Nodule / cyst / polyp — descriptive terms, not diagnoses |
| 脉胎脉硬化 / 脂肪肝 | dòngmài yìnghuà / zhīfáng gān | Arteriosclerosis / fatty liver — two of the most frequent flags |
| 待查 | dài chá | To be determined — the report is explicitly not concluding |
Two structural points worth knowing. Chinese reference ranges are published in SI units, so a value that looks alarming to an American eye may simply be on a different scale — the conversion table is on blood test cost in China. And the summary page is written by a reviewing physician who has not usually met you and has no access to your history, which is exactly why so many lines end in "recommend further examination" rather than a conclusion.
The classification systems you will actually meet
Chinese hospitals grade certain common findings against published risk-stratification systems rather than describing them freehand. Seeing a category number is not a diagnosis — it is the radiologist placing the finding on a standard scale so that the next clinician knows what they are looking at.
Thyroid nodules — C-TIRADS
Thyroid nodules are the single most common incidental finding on a Chinese screening ultrasound, and most Chinese hospitals grade them with C-TIRADS, the Chinese Thyroid Imaging Reporting and Data System published in the 2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules. The published risk bands are:
| C-TIRADS category | Published malignancy risk |
|---|---|
| 3 | ≤ ~2% |
| 4A | 2–10% |
| 4B | 10–50% |
| 4C | 50–90% |
| 5 | > 90% |
The reason to know this scale is proportion. A great many screening reports return a category 3 or 4A nodule, and the standard response to those is an interval re-scan rather than intervention. What the number cannot do is tell you what to do next — that depends on nodule size, growth, your history and clinical examination, and is a conversation with an endocrinologist or thyroid surgeon, not a web page.
Breast findings — BI-RADS
Breast ultrasound and mammography in China are reported on BI-RADS, the same internationally used scale a radiologist at home will recognise, running from category 1 (negative) through 3 (probably benign, short-interval follow-up conventionally suggested) and 4 (suspicious, subdivided 4A–4C) to 5 (highly suggestive) and 6 (biopsy-proven). Because it is an international standard, a BI-RADS number travels across borders cleanly even when the surrounding report does not — a genuine advantage when you are taking findings home.
Lung nodules on low-dose CT
Low-dose chest CT is included in most mid- and upper-tier Chinese packages and is very good at finding small pulmonary nodules — 肺结节, and specifically 肺磨玻璃结节 for the ground-glass subtype. Detection of small nodules on screening CT is common, and the conventional response is interval imaging determined by size and appearance rather than immediate action; reports usually state the recommended interval explicitly. The relevant practical point for a traveller is that a follow-up scan is only interpretable against the original, so the baseline images matter as much as the report. Dose figures and scan pricing are on CT scan cost in China.
Tumour markers
Tumour-marker panels — CEA, AFP, CA-125, CA19-9 and others — are sold aggressively as add-ons in the Chinese screening market and are a leading cause of unnecessary alarm. They are not validated as population screening tests in people without symptoms: they rise in a range of benign conditions and can sit in the normal range in the presence of disease. A single mildly elevated marker in an otherwise normal screen commonly prompts a repeat after an interval rather than an investigation. We cover what the panels do and don't establish on cancer screening in China for foreigners.
What follow-up costs, and what it costs to delay
These are 2026 planning ranges at a public Grade IIIA hospital. A private international hospital will charge several times these figures for the same items — the mechanism behind that gap is explained on checkup cost by hospital type.
| Follow-up step | Public Grade IIIA (2026) | Typical turnaround |
|---|---|---|
| Repeat targeted ultrasound | ¥120–300 | Same day |
| Specialist consultation | ¥50–600 general clinic vs VIP/international | Same or next day |
| Repeat blood panel | ¥40–250 | 2–6 hours |
| Contrast-enhanced CT or MRI | ¥900–2,000 | 1–3 days |
| Thyroid fine-needle aspiration + cytology | ¥800–2,500 | 3–7 days |
| Gastroscopy or colonoscopy (diagnostic) | ¥500–2,500 | 1–5 days to slot |
| Biopsy histopathology | ¥300–1,200 | 5–10 days |
Two scheduling facts shape the decision. Pathology and cytology results take five to ten days in most Chinese hospitals, which is longer than many checkup trips. And endoscopy under sedation usually cannot be slotted the same day — see endoscopy cost in China and how many days a checkup takes for how this fits a trip plan.
Set aside a contingency of roughly 20–30% of the package price before you travel. It is very often unspent, and when it is needed it removes the worst version of this situation: discovering a finding, and then deciding what to do about it on the basis of what you can afford that week.
Stay in China, or take it home?
The dividing line that holds up in practice is tests versus treatment.
- Stay for tests. Repeat imaging, a specialist opinion, a targeted ultrasound, a contrast study — these are fast, inexpensive and performed by people who already have your baseline images on their system. Two to four extra days usually resolves the question, and doing it here is very often cheaper than the same work-up at home even after the hotel nights.
- Go home for treatment. Anything that begins a course of care — surgery, an oncology pathway, ongoing medication, anything needing months of monitoring — is generally better started where your own physician practises and your insurer pays. Cross-border continuity is the part that reliably goes wrong, not the initial procedure.
- Check whether there is anything to decide. A large share of recommendations carry a three-, six- or twelve-month interval. If yours does, the correct action is to note the date, take the files home, and give them to your own doctor — not to extend the trip.
If you do stay, book the follow-up through the same institution that did the screen wherever possible. A department that can pull up the original images resolves in one visit what a new hospital will restart from scratch. The English-language routes for that conversation are on English-speaking hospitals in China.
What to collect before you leave
This is the part travellers get wrong, and it is expensive to fix from another country. Ask at the desk before you check out, not by email afterwards.
- The full itemised report, not just the summary page — the numbers and the descriptive imaging text, which is what a radiologist at home will want to read.
- Raw imaging as DICOM files on a disc, USB or cloud link. Printed films and photographs of a screen are close to useless to a radiologist. Chinese hospitals increasingly release imaging as a 云胶片 cloud-image link accessed by QR code — ask how long the link stays live, because some expire within weeks, and download the files while you are still in the country.
- Any pathology or cytology report with its specimen number.
- The reporting physician's department and a contact number, plus the patient or accession identifier the hospital files studies under — without it, requesting anything later is very difficult.
- An English report, requested at booking rather than retro-fitted. The routes are on getting your results in English; if you have already left, translation runs roughly $20–60 a page — see medical records translation and translating a Chinese medical report.
What your own physician will need when you hand this over, and how to present it so it gets used rather than filed, is set out on giving Chinese records to your home doctor.
Three things not to do
- Don't act on a screening flag as though it were a diagnosis. Screening tests are built to be over-sensitive on purpose; that is what makes them useful, and it is also why most flags resolve to nothing.
- Don't leave without the raw images. A report without its DICOM files forces a repeat scan at home — which is both the expense and the radiation you came here to plan carefully.
- Don't start treatment abroad on the strength of a single number without a clinician who has your history reviewing it. That includes the tumour-marker panel, and it includes anything sold to you at the counter on the day.
Frequently asked questions
Is follow-up included in the price of a health checkup in China?
No. At every tier — screening chain, public hospital health-management centre, international or VIP department, or private international hospital — the package price covers the listed examinations and the report. Any repeat test, additional scan, specialist consultation or biopsy prompted by a finding is billed separately. As 2026 planning ranges, a repeat targeted ultrasound is roughly ¥120–300, a specialist consultation ¥50–600 depending on route, a contrast-enhanced CT or MRI ¥900–2,000, and a thyroid fine-needle aspiration with cytology ¥800–2,500. Budget a contingency of roughly 20–30% of the package price.
What does 建议进一步检查 mean on a Chinese checkup report?
It means "further examination recommended" — the reporting physician has seen something the screening test cannot resolve and is directing you to a more specific test, not making a diagnosis. It is one of a small set of standard closing phrases: 建议复查 means repeat or re-check, usually with an interval attached such as 三个月复查 (recheck in three months); 建议专科就诊 means see the relevant specialist department; 定期随访 means routine periodic follow-up. The interval attached to the phrase is the most informative part, because it signals how urgent the reporting physician considers the finding.
What do the C-TIRADS categories mean on a Chinese thyroid ultrasound?
C-TIRADS is the Chinese Thyroid Imaging Reporting and Data System, published in the 2020 Chinese guidelines for ultrasound malignancy risk stratification of thyroid nodules, and it is what most Chinese hospitals use to grade a thyroid nodule. Its published malignancy-risk bands are: category 3 approximately 2% or less, category 4A 2–10%, category 4B 10–50%, category 4C 50–90%, and category 5 above 90%. Thyroid nodules are extremely common incidental findings on screening ultrasound. The grade is a risk estimate to guide whether further assessment is warranted, not a diagnosis, and only the clinician managing your care can advise what it means for you.
Should I stay in China to complete follow-up or take the results home?
The practical dividing line is whether the next step is a test or a treatment. Repeat imaging, a specialist opinion and most laboratory re-tests are fast and inexpensive in China and can often be completed in two to four extra days, which is usually worth staying for. Anything that starts a course of treatment, or that will need continuity — surgery, an oncology pathway, long-term medication — is generally better handled where your own physician and your insurer are, because follow-up care across borders is the part that goes wrong. Also weigh whether the finding needs a same-week answer at all: many recommendations carry a three- to twelve-month interval, in which case there is nothing to rush.
What should I collect before leaving China if something was flagged?
Five things, and ask for all of them before you check out rather than by email afterwards. The full itemised report rather than the summary page; the raw imaging as DICOM files on a disc or a cloud-image link, because printed films are not usable by a radiologist abroad; any pathology or cytology report with its specimen number; the hospital's name, department and a contact number for the reporting physician; and the patient or accession identifier the hospital files your studies under. An English report is far cheaper to request at booking than to commission later at roughly $20–60 a page.
Are tumour markers a reliable way to detect cancer on a Chinese checkup?
No, and a single mildly raised marker is one of the most common causes of unnecessary alarm on Chinese checkup reports. Tumour markers such as CEA, AFP, CA-125 and CA19-9 are widely sold as package add-ons in China, but they are not validated as population screening tests in people without symptoms: they rise in many benign conditions and can be normal in the presence of disease. Interpretation depends entirely on clinical context and trend over time rather than a single number. What a raised marker usually prompts is a repeat test after an interval, not immediate further investigation.
Can I get a second opinion on Chinese imaging after I get home?
Yes, and it is straightforward provided you left with the right files. A radiologist anywhere can open DICOM files, because the format is international and the images carry no language. What does need translating is the written report and any pathology, which runs roughly $20–60 a page for a certified translation. Hospitals in China increasingly release imaging through a cloud-image service (云胶片) accessed by QR code rather than a physical disc — check how long that link stays live before you leave, as some expire within weeks.